Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
$49.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AbbVie Inc Reaffirms FY 2013 EPS Guidance


Friday, 26 Apr 2013 07:51am EDT 

AbbVie Inc announced that it is confirming its diluted earnings-per-share (EPS) guidance for fiscal 2013 of $2.66 to $2.76 on a GAAP basis, or $3.03 to $3.13 on an adjusted basis. The Company's 2013 adjusted diluted earnings-per-share guidance excludes $0.37 per share of intangible asset amortization expense and other specified items, primarily associated with certain separation-related costs and previously announced ongoing restructuring activities. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report EPS of $3.11 for fiscal 2013. 

Company Quote

59.45
-0.17 -0.29%
18 Sep 2014